Abstract
Major depressive disorder (MDD) is associated to affected brain wiring. Little is known whether these changes are stable over time and hence might represent a biological predisposition, or whether these are state markers of current disease severity and recovery after a depressive episode. Human white matter network ("connectome") analysis via network science is a suitable tool to investigate the association between affected brain connectivity and MDD. This study examines structural connectome topology in 464 MDD patients (mean age: 36.6 years) and 432 healthy controls (35.6 years). MDD patients were stratified categorially by current disease status (acute vs. partial remission vs. full remission) based on DSM-IV criteria. Current symptom severity was assessed continuously via the Hamilton Depression Rating Scale (HAMD). Connectome matrices were created via a combination of T1-weighted magnetic resonance imaging (MRI) and tractography methods based on diffusion-weighted imaging. Global tract-based metrics were not found to show significant differences between disease status groups, suggesting conserved global brain connectivity in MDD. In contrast, reduced global fractional anisotropy (FA) was observed specifically in acute depressed patients compared to fully remitted patients and healthy controls. Within the MDD patients, FA in a subnetwork including frontal, temporal, insular, and parietal nodes was negatively associated with HAMD, an effect remaining when correcting for lifetime disease severity. Therefore, our findings provide new evidence of MDD to be associated with structural, yet dynamic, state-dependent connectome alterations, which covary with current disease severity and remission status after a depressive episode.
Original language | English |
---|---|
Pages (from-to) | 1550-1558 |
Number of pages | 9 |
Journal | Molecular Psychiatry |
Volume | 25 |
Issue number | 7 |
Early online date | 22 Nov 2019 |
DOIs | |
Publication status | Published - Jul 2020 |
Funding
Acknowledgements This work is part of the German multicenter consortium “Neurobiology of Affective Disorders. A translational perspective on brain structure and function“, funded by the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; For-schungsgruppe/Research Unit FOR2107). Principal investigators (PIs) with respective areas of responsibility in the FOR2107 consortium are: Work Package WP1, FOR2107/MACS cohort and brain imaging: Tilo Kircher (speaker FOR2107; DFG grant numbers KI 588/14-1, KI 588/ 14-2), Udo Dannlowski (co-speaker FOR2107; DA 1151/5-1, DA 1151/5-2), Axel Krug (KR 3822/5-1, KR 3822/7-2), Igor Nenadic (NE 2254/1-2), Carsten Konrad (KO 4291/3-1). CP1, biobank: Petra Pfefferle (PF 784/1-1, PF 784/1-2), Harald Renz (RE 737/20-1, 737/ 20-2). CP2, administration. Tilo Kircher (KI 588/15-1, KI 588/17-1), Udo Dannlowski (DA 1151/6-1), Carsten Konrad (KO 4291/4-1). Martijn van den Heuvel was supported by an ALW open (ALWOP.179), and VIDI (452-16-015) grant from the Netherlands Funding This work was funded by the German Research Foundation (DFG, grant FOR2107 DA 1151/5-1 and DA 1151/5-2 to UD; SFB-TRR58, Projects C09 and Z02 to UD), the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Münster (grant Dan3/012/17 to UD), IMF Münster RE111604 to RR und RE111722 to RR, IMF Münster RE 22 17 07 to Jonathan Repple and the Deanery of the Medical Faculty of the University of Münster. The FOR2107 cohort project (WP1) was approved by the Ethics Committees of the Medical Faculties, University of Marburg (AZ: 07/14), and University of Münster (AZ: 2014-422-b-S).
Funders | Funder number |
---|---|
IZKF | Dan3/012/17 |
Interdisciplinary Center for Clinical Research | |
Medical Faculty of the University of Münster | |
VIDI | 452-16-015 |
International Monetary Fund | RE111604, RE111722 |
Deutsche Forschungsgemeinschaft | RR, FOR2107, FOR2107 DA 1151/5-1, DA 1151/5-2, Z02 |
German-Israeli Foundation for Scientific Research and Development | |
Astellas Pharma, Netherlands |